Adaptive Biotechnologies Corporation (Nasdaq: ADPT) to Ring The Nasdaq Stock Market Opening Bell
June 27 2019 - 7:00AM
What: Adaptive Biotechnologies Corporation
(Nasdaq: ADPT), a commercial-stage biotechnology company that reads
and translates the genetic code of the adaptive immune system to
develop personalized diagnostics and therapeutics to improve
patient lives, will visit the Nasdaq MarketSite in Times
Square.
In honor of the occasion, Chad Robins, Chief Executive
Officer & Co-Founder, and Harlan Robins, Chief Scientific
Officer & Co-Founder, will ring the Opening Bell
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Thursday, June 27, 2019 – 9:15 a.m. to
9:30 a.m. ET
Adaptive Biotechnologies Corporation Media
Contact:Beth
Keshishian917-912-7195media@adaptivebiotech.com
Nasdaq MarketSite Media Contact:Bianca
Fata(646) 441-5073bianca.fata@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Opening
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Open, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market open of your choice.
About Adaptive Biotechnologies
CorporationAdaptive Biotechnologies is a commercial-stage
biotech company focused on harnessing the inherent biology of the
adaptive immune system to transform the diagnosis and treatment of
disease. We believe the adaptive immune system is nature’s most
finely tuned diagnostic and therapeutic for most diseases, but the
inability to decode it has prevented the medical community from
fully leveraging its capabilities. Our proprietary immune medicine
platform reveals and translates the massive genetics of the
adaptive immune system with unprecedented scale, precision and
speed to develop products in life sciences research, clinical
diagnostics, and drug discovery. We have two commercial products,
and a robust clinical pipeline to diagnose, monitor and enable the
treatment of diseases such as cancer, autoimmune conditions and
infectious diseases. Our goal is to develop and commercialize
immune-driven clinical products tailored to each individual
patient. For more information, please visit
adaptivebiotech.com.
About Nasdaq:Nasdaq (Nasdaq: NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 100
marketplaces in 50 countries. Nasdaq is home to approximately 4,000
total listings with a market value of approximately $14 trillion.
To learn more, visit: http://business.nasdaq.com.
-NDAQA-
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Sep 2023 to Sep 2024